Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio D'Ascenzo and Sergio Raposeiras-Roubín.
Connection Strength
2.844
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
Score: 0.785
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020 Oct; 9(7):764-770.
Score: 0.205
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.203
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
Score: 0.197
-
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry. Am J Cardiovasc Drugs. 2018 Aug; 18(4):299-309.
Score: 0.195
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
Score: 0.194
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
Score: 0.193
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score. Int J Cardiol. 2018 03 01; 254:10-15.
Score: 0.188
-
[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. Rev Esp Cardiol. 2021 Jul; 74(7):608-615.
Score: 0.058
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry. Rev Esp Cardiol (Engl Ed). 2021 Jul; 74(7):608-615.
Score: 0.058
-
Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
Score: 0.057
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
Score: 0.057
-
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design. Contemp Clin Trials Commun. 2020 Dec; 20:100654.
Score: 0.057
-
Outcomes of acute coronary syndromes in coronavirus disease 2019. Clin Res Cardiol. 2020 Dec; 109(12):1601-1604.
Score: 0.056
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 08; 33(4):737-745.
Score: 0.056
-
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. Thromb Res. 2018 08; 168:156-163.
Score: 0.048
-
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
Score: 0.048
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018 07; 167:142-148.
Score: 0.048
-
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry. Thromb Haemost. 2018 05; 118(5):929-938.
Score: 0.048
-
Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice. J Geriatr Cardiol. 2017 Nov; 14(11):679-687.
Score: 0.046
-
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. EuroIntervention. 2017 Jul 20; 13(4):407-414.
Score: 0.045